Hakutulokset - Mathilda Mandel

Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation. Tekijä Naama Dror, Mathilda Mandel, Gad Lavie

Hae kokoteksti

Coronavirus 2019 outbreak pathogenesis: Why China and Italy? Tekijä Anat Achiron, Mathilda Mandel, Yehuda Sheonefeld

Hae kokoteksti

Advances in Microbial Biofilm Prevention on Indwelling Medical Devices with Emphasis on Usage of Acoustic Energy Tekijä Gad Lavie, Zadik Hazan, Mathilda Mandel, Naama Dror

Hae kokoteksti

Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. Tekijä Tilda Barliya, Mathilda Mandel, Tami Livnat, Dov Weinberger, Gad Lavie

Hae kokoteksti

Unique Gene Expression Patterns in Human T-cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide Tekijä Mathilda Mandel, Anat Achiron, Gad Lavie, Irun R. Cohen, Michael Gurevich

Hae kokoteksti

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation Tekijä Anat Achiron, Rina Falb, Shay Menascu, David Magalashvili, Mathilda Mandel, Polina Sonis, Michael Gurevich

Hae kokoteksti

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients Tekijä Michael Gurevich, Rina Zilkha-Falb, Polina Sonis, David Magalashvili, Shay Menascu, Shlomo Flechter, Mark Dolev, Mathilda Mandel, Anat Achiron

Hae kokoteksti

Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis Tekijä Shay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, Yehuda Warszawer, David Magalashvili, Mark Dolev, Mathilda Mandel, Gil Harari, Anat Achiron

Hae kokoteksti

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies Tekijä Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich

Hae kokoteksti

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies Tekijä Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich

Hae kokoteksti